PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells

被引:813
作者
Boire, A
Covic, L
Agarwal, A
Jacques, S
Sherifl, S
Kuliopulos, A [1 ]
机构
[1] Tufts Univ, Sch Med, Mol Oncol Res Inst, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Div Hematol Oncol, Tufts New England Med Ctr, Boston, MA 02111 USA
[3] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
[4] Mt Auburn Hosp, Dept Pathol, Cambridge, MA 02138 USA
关键词
D O I
10.1016/j.cell.2004.12.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Protease-activated receptors (PARs) are a unique class of G protein-coupled receptors that play critical roles in thrombosis, inflammation, and vascular biology. PAR1 is proposed to be involved in the invasive and metastatic processes of various cancers. However, the protease responsible for activating the pro-invasive functions of PAR1 remains to be identified. Here, we show that expression of PAR1 is both required and sufficient to promote growth and invasion of breast carcinoma cells in a xenograft model. Further, we show that the matrix metalloprotease, MMP-1, functions as a protease agonist of PAR1 cleaving the receptor at the proper site to generate PAR1-dependent Ca2+ signals and migration. MMP-1 activity is derived from fibroblasts and is absent from the breast cancer cells. These results demonstrate that MMP-1 in the stromal-tumor microenvironment can alter the behavior of cancer cells through PAR1 to promote cell migration and invasion.
引用
收藏
页码:303 / 313
页数:11
相关论文
共 45 条
[1]
Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor [J].
Andrade-Gordon, P ;
Mayanoff, BE ;
Derian, CK ;
Zhang, HC ;
Addo, MF ;
Darrow, AL ;
Eckardt, AJ ;
Hoekstra, WJ ;
McComsey, DF ;
Oksenberg, D ;
Reynolds, EE ;
Santulli, RJ ;
Scarborough, RM ;
Smith, CE ;
White, KB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12257-12262
[2]
Development of potent thrombin receptor antagonist peptides [J].
Bernatowicz, MS ;
Klimas, CE ;
Hartl, KS ;
Peluso, M ;
Allegretto, NJ ;
Seiler, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) :4879-4887
[3]
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa [J].
Camerer, E ;
Huang, W ;
Coughlin, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5255-5260
[4]
Thrombin induces neoangiogenesis in the chick chorioallantoic membrane [J].
Caunt, M ;
Huang, YQ ;
Brooks, PC ;
Karpatkin, S .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (10) :2097-2102
[5]
CHEN J, 1994, J BIOL CHEM, V269, P16041
[6]
Thrombin signalling and protease-activated receptors [J].
Coughlin, SR .
NATURE, 2000, 407 (6801) :258-264
[7]
Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides [J].
Covic, L ;
Gresser, AL ;
Talavera, J ;
Swift, S ;
Kuliopulos, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :643-648
[8]
Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation [J].
Covic, L ;
Misra, M ;
Badar, J ;
Singh, C ;
Kuliopulos, A .
NATURE MEDICINE, 2002, 8 (10) :1161-1165
[9]
New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[10]
Thrombin receptor overexpression in malignant and physiological invasion processes [J].
Even-Ram, S ;
Uziely, B ;
Cohen, P ;
Grisaru-Granovsky, S ;
Maoz, M ;
Ginzburg, Y ;
Reich, R ;
Vlodavsky, I ;
Bar-Shavit, R .
NATURE MEDICINE, 1998, 4 (08) :909-914